Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy.

about

Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy.

Item

http://www.wikidata.org/entity/Q44345567

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Discrepancy Between Clinical a ...... osis and Therapeutic Strategy.

@en

Discrepancy Between Clinical a ...... osis and Therapeutic Strategy.

@nl

type

Item

label

Discrepancy Between Clinical a ...... osis and Therapeutic Strategy.

@en

Discrepancy Between Clinical a ...... osis and Therapeutic Strategy.

@nl

prefLabel

Discrepancy Between Clinical a ...... osis and Therapeutic Strategy.

@en

Discrepancy Between Clinical a ...... osis and Therapeutic Strategy.

@nl

P1476

Discrepancy Between Clinical a ...... osis and Therapeutic Strategy.

@en

P2093

Alain Duhamel

http://www.w3.org/2001/XMLSchema#string

Arnaud Pasquer

http://www.w3.org/2001/XMLSchema#string

Caroline Gronnier

http://www.w3.org/2001/XMLSchema#string

Christophe Mariette

http://www.w3.org/2001/XMLSchema#string

Cécile Brigand

http://www.w3.org/2001/XMLSchema#string

Denis Collet

http://www.w3.org/2001/XMLSchema#string

FREGAT Working Group—FRENCH—AFC

http://www.w3.org/2001/XMLSchema#string

Florence Renaud

http://www.w3.org/2001/XMLSchema#string

Gil Lebreton

http://www.w3.org/2001/XMLSchema#string

Guillaume Piessen

http://www.w3.org/2001/XMLSchema#string

P2860

Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial.

Oesophagogastric junction adenocarcinoma: which therapeutic approach?

Pattern of Postoperative Mortality After Esophageal Cancer Resection According to Center Volume: Results from a Large European Multicenter Study.

Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study.

Is Centralization Needed for Esophageal and Gastric Cancer Patients With Low Operative Risk?: A Nationwide Study.

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.

Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.

P2888

s10434-017-6088-8

P304

3911-3920

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-6088-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bernard Meunier

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091920587

http://www.w3.org/2001/XMLSchema#string

P698

28948524

http://www.w3.org/2001/XMLSchema#string

P932

5670185

http://www.w3.org/2001/XMLSchema#string